{"id":"W4312157419","doi":"10.1016/j.msard.2022.104477","title":"Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"NeuroRx Research (Canada); Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame","funders":"Sanofi Genzyme; Multiple Sclerosis Society; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Glatiramer acetate; Hazard ratio; Internal medicine; Confidence interval; Physical therapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001251203,0.0005405758,0.001284645,0.0005848591,0.0007673901,0.00005070803,0.0002188961,0.0001345661,0.00005832197],"category_scores_gemma":[0.001570533,0.0004275287,0.0002050984,0.001144086,0.0002993826,0.0002404624,0.0008949367,0.0008556321,0.000003250056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002714787,"about_ca_system_score_gemma":0.0001148446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0023433,"about_ca_topic_score_gemma":0.0008795485,"domain_scores_codex":[0.995786,0.001065177,0.0005901016,0.001043755,0.0007873682,0.0007276086],"domain_scores_gemma":[0.9961846,0.002507862,0.0002085498,0.0004871185,0.00008723418,0.0005245865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05077597,0.00174148,0.7151246,0.001751999,0.0007347588,0.00002252282,0.008175602,0.006302175,0.1383712,0.00001389455,0.00009073191,0.07689507],"study_design_scores_gemma":[0.01848437,0.002223541,0.9467803,0.001181284,0.0001467197,0.000004988171,0.001029325,0.02597234,0.00365183,0.00001310897,0.00007260706,0.0004396379],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931293,0.001809278,0.00006798907,0.0005198217,0.000149489,0.003988163,0.0001635368,0.0000995552,0.00007290283],"genre_scores_gemma":[0.9970625,0.001322812,0.00009821221,0.00004262322,0.00001586807,0.001328746,0.00003005298,0.00006555048,0.00003360239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2316556,"threshold_uncertainty_score":0.9998177,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04864018171732619,"score_gpt":0.3034846335300865,"score_spread":0.2548444518127603,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}